SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Farming

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jon Koplik who wrote (99)11/5/2000 9:59:53 AM
From: Jon Koplik  Read Replies (1) of 4440
 
(Organic (!)) Pesticide Found to Produce Parkinson's Symptoms in Rats.

November 5, 2000

Pesticide Found to Produce Parkinson's
Symptoms in Rats

By SANDRA BLAKESLEE

NEW ORLEANS, Nov. 4 — An organic
pesticide widely used on home-grown
fruits and vegetables and for killing
unwanted fish in the nation's lakes and rivers
produces all the classic symptoms of Parkinson's
disease in rats that receive steady amounts of the
chemical in their bloodstreams, scientists said
today.

While it is much too soon to say that the pesticide, rotenone, causes or
contributes to Parkinson's disease in humans, the scientists said the finding
was the best evidence thus far that chemicals in the environment may be
factors in this devastating disease.

Their study, the first to implicate rotenone in Parkinson's disease, was
described here today at a workshop on the neurobiology of disease, held in
conjunction with the annual meeting of the Society for Neuroscience, the
nation's largest gathering of brain researchers. The workshop, sponsored by
the National Institute of Neurological Disorders and Stroke, involved work
carried out by Dr. Timothy Greenamyre and colleagues at Emory University
in Atlanta. The results of the study will be published in the December issue of
the journal Nature Neuroscience.

"This is a very important new study," said Dr. William Langston, president of
the Parkinson's Institute, a leading center for research and treatment of the
disease in Sunnyvale, Calif. "It is the next major step in Parkinson's disease
research."

Dr. John Q. Trojanowski, an expert on neurodegenerative diseases at the
University of Pennsylvania School of Medicine in Philadelphia and the
moderator of the workshop, said, "This is the best model we have ever had
for this disease being associated with an environmental agent."

But Dr. Trojanowski cautioned that the findings "may not represent what
anyone would experience in the real world." For one thing, the rats in the
study were exposed to the chemical through their jugular veins, so it was not
broken down or metabolized in the digestive tract. Still, Dr. Trojanowski said,
the results are "a major breakthrough" and "prompt us to look at how a
lifetime exposure" to a chemical or combination of chemicals might actually
lead to Parkinson's disease.

Rotenone is extracted from the dried roots, seeds and leaves of various
tropical plants, including the Jewel vine, derris and hoary pea.
Like many
plants that produce what are in effect their own pesticides, these plants
apparently evolved to produce the compound as a way of warding off insects
and other pests.

Rotenone is found in 680 compounds marketed as organic garden pesticides
and flea powders, said Dr. Caroline Tanner, director of clinical research at
the Parkinson's Institute. It is often sold as a white powder that is dusted
onto roses, tomatoes, pears, apples and African violets, and even on
household pets. It kills fire ants.

Because rotenone is naturally occurring, it is advertised as being safer than
synthetic pesticides,
she said. In addition, unlike many artificial pesticides,
which linger in the environment, rotenone breaks down in five to six days of
spring sunlight or two to three days of summer sunlight.

Rotenone is also widely used in liquid form by fishery managers to destroy
pest species. The chemical is added to lakes and reservoirs, where it kills all
the fish by inhibiting their ability to use oxygen. Once it has degraded, the
water is restocked with the desired fish species.

Parkinson's disease is one of the most common neurodegenerative diseases,
affecting nearly one million Americans over the age of 50. The disease is
caused by the steady loss of cells, in a tiny region of the brain called the
substantia nigra, that produce a chemical, dopamine, which is crucial for
movement and cognition. Patients develop jerky, tremulous movements that
get worse with time. Eventually they become entirely rigid.

A hallmark of the disease is that dopamine cells in the substantia nigra
become clogged with tiny, gunky clumps of abnormal protein called Lewy
bodies.

Scientists have suspected since the middle of the 19th century that an
environmental toxin might be involved in Parkinson's disease, Dr. Tanner
said. Moreover, people who work on farms or live in the countryside have as
much as seven times as much risk of developing the disease as other people.


The first real clues to understanding the disease were found in 1983 when a
number of young addicts using contaminated heroin developed severe
Parkinson's-like symptoms. Researchers found that the drug had left
dopamine-producing cells damaged much as they are damaged in Parkinson's
disease and blocked the action of an important enzyme called complex one.

But mysteries remained. Why do dopamine-producing cells in just one tiny
part of the brain die from lack of complex one, while other cells in the body
and brain, including other dopamine-producing cells, are affected but do not
necessarily shut down? And why were there no Lewy bodies?

Dr. Greenamyre, a professor of neurology and pharmacology at Emory, said
he thought rotenone might offer a better model of the disease. It is a known
complex one inhibitor, he said, and "it is used in a zillion products."

In the study, rats were given a steady low dose of rotenone directly into their
bloodstreams for one to five weeks, Dr. Greenamyre said. The chemical
could therefore pass more easily into the brain and not get broken down in
the intestines. During the exposure, the rats grew stiff, stopped moving as
much, hunched over and developed tremors — just the kinds of problems
that develop in Parkinson's disease.

"When we examined their brains we saw that they had a progressive
degeneration of the dopamine system that goes awry in Parkinson's," Dr.
Greenamyre said. "It was extremely specific." And for the first time,
scientists observed evidence of Lewy bodies.

But it remains to be seen if rotenone is a factor in human disease. Not
everyone who uses it gets the disease. It may be one of many toxins that
have to work in concert before Parkinson's will develop in the brain; rotenone
alone may be relatively harmless for people.

Moreover, people may vary in their susceptibility to rotenone and similar
chemicals, Dr. Greenamyre said.

Copyright 2000 The New York Times Company
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext